Confidentiality of Substance Use Disorder Patient Records; Complying with the New Federal Law 42 CFR Part 2
Objectives of the Presentation
Recall that the federal law on drug and alcohol records has been rewritten and is now known as confidentiality of substance use disorder records
Discuss when a minor can consent to the treatment of substance abuse disorder
Explain that a special consent form is needed to release the medical records of a patient treated for substance abuse disorder in a part 2 program
Describe when a report of a violation must be reported and to whom
Why Should you Attend
The webinar will discuss what is required of part 2 programs. A facility that receives federal assistance (such as Medicare) and hold itself out as providing substance use disorder diagnosis, treatment, or referral must follow these extensive regulations. They address the notice that must be given to the patient. It discusses patient access to medical records and what must be in the consent form. It discusses research, closure of a program, new definitions, minors, decease patient records, security of medical records, disclosure, when disclosure is prohibited and more.
If a patient is admitted to a hospital to the substance use disorder treatment floor
Are you up to speed on how to comply with the many requirements of this law?
What is the responsibility if the patient being treated for drug or alcohol abuse discloses he or she has abused their children?
When can minors consent to treatment?
When can the parents of a minor get access to their records?
What is the patient commits a crime on the property?
All of these questions will be answered in this webinar.
Introduction and history
Previously called confidentiality of drug and alcohol records
Substance use disorder patient records
How to locate a copy of the law
Substance use disorder data
American Hospital Association recommendations
Purpose and need of new law
Who is subjected to the law under part 2
Federally assisted and holding one out
More rules in round two
Sub-regulatory guidance´s will be issued
Notice to patients of confidentiality requirements
Patient access to medical records and restrictions on use
Reports of violations or penalties
Security of medical records
Restrictions on disclosure
Crimes on the premises and child abuse reports
Prohibitions on re-disclosure
Relationship to state laws
Disclosures with consent
Disclosures to the criminal justice system
Disclosure without consent
Informants and undercover agents
Closing a program
Audits and evaluation
OCR and HIPAA and mental health records
Who will Benefit
Anyone who takes care of patients in a part 2 program should attend. This includes staffs that take care of patients in a program that is federally assisted and who holds themselves out as providing care and treatment to patients who have a substance use disorder (SUD). This includes: Quality Improvement Staff, Physicians, Nurses (all levels), Board Members, Clinic Managers, Outpatient Directors, Lab Directors, Compliance Officers, CMS Liaisons, Registration Staff, Safety Officers and Staff, Pharmacy Staff, Ethics Committee Members, Risk Managers, Legal Counsel, Behavioral Health Staff, Psychiatry Staff, Discharge Planners, Case Managers, CEOs, COOs, CMOs, CNOs, CE Directors